If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ subscription, which is 50% off through next Monday.

TB Alternative Assets Ltd. has joined the biotech investing party by purchasing 3,158 shares of Regeneron Pharmaceuticals ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

A number of US states are taking legal action against the sale of 23andMe and its DNA data. A sale is only acceptable with ...

Me was founded in 2006 and pioneered the direct-to-consumer genetic testing model. Customers responded positively, ordering ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

( NewsNation) — The interim CEO of 23andMe will face questions from lawmakers Wednesday about the DNA company’s data privacy amid a multistate lawsuit about its customers’ genetic data. The Senate ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety and promising objective response rates in patients with few treatment choices ...

Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and ...